FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diphenhydramine Injection
Status: Currently in Shortage
»Date first posted: 09/14/2018
»Therapeutic Categories: Pediatric; Pulmonary/Allergy

Expand all

Fresenius Kabi USA, LLC (Revised 10/15/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg per vial, Single dose, Amber vial (NDC 63323-664-01) Backordered. Next release October 2018. Demand increase for the drug

Hospira, Inc. (Reverified 10/11/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL Carpuject™ Luer Lock Glass Syringe (NDC 00409-2290-31) Next Delivery and Estimated Recovery: 2019 Shortage per Manufacturer: Manufacturing Delay Other

Mylan Institutional (Revised 10/08/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg / 10mL(NDC 67457-124-10) Unavailable. Expected recovery: Q1 2019 On manual allocation Other

West-Ward Pharmaceuticals (Revised 10/03/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 1 mL vial (NDC 0641-0376-25) Currently on backorder. Additional lots are scheduled to be manufactured in the October 2018 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English